retatrutide clinical data retatrutide vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness obesitymedicine #retatrutide #clinicaldata #osteoarthritis #elililly

Although the observed increase in risk is small on an individual level, the broad adoption of GLP1-RAs for weight management amplifies its potential implications at the population level, underscoring the need for heightened awareness among clinicians and patients about the dermatologic effects of these medications, the authors wrote

The test is optional and designed to support deeper personalization conversations with your provider

Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, et al

It is indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher if weight-related conditions like type 2 diabetes, hypertension, or dyslipidemia exist